AnCaps
ANARCHO-CAPITALISTS
Bitch-Slapping Statists For Fun & Profit Based On The Non-Aggression Principle
 
HomePortalGalleryCalendarFAQRegisterLog in
 

 Evolocumab significantly reduces risk of cardiovascular events

View previous topic View next topic Go down 
AuthorMessage
CovOps

avatar

Female Location : Ether-Sphere
Job/hobbies : Irrationality Exterminator
Humor : Über Serious

PostSubject: Evolocumab significantly reduces risk of cardiovascular events   Tue Mar 21, 2017 5:47 am

Evolocumab, one of the new targeted PCSK9 inhibitor drugs that has been shown to dramatically lower levels of low-density lipoprotein (LDL), or “bad” cholesterol, also significantly lowers the risk of cardiovascular events in patients with existing heart or vascular disease already on statin therapy, according to new research.

https://www.sciencedaily.com/releases/2017/03/170317132012.htm
_________________
Anarcho-Capitalist, AnCaps Forum, Ancapolis, The Dark Side, Post-Apocalypse, OZschwitz Contraband
Back to top Go down
 

Evolocumab significantly reduces risk of cardiovascular events

View previous topic View next topic Back to top 
Page 1 of 1

Permissions in this forum:You cannot reply to topics in this forum
 :: Anarcho-Capitalist Categorical Imperatives :: AnCaps In Science, Technology & Environment-